Lupin spins out two cancer drug programmes to new US venture for $1.6 million stake
Lupin spins out two cancer drug programmes to new US venture for $1.6 million stake — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.
Lupin spins out two cancer drug programmes to new US venture for $1.6 million stake — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.